What is Microgen Biotech?
Microgen Biotech operates at the intersection of agricultural science and food safety, specializing in the development of natural microbial solutions designed to inhibit the uptake of heavy metals like arsenic and cadmium in food crops. By leveraging non-engineered, native microbial strains, the company offers a sustainable alternative to traditional chemical interventions. This approach not only addresses critical health concerns regarding soil-to-crop contamination but also provides food enterprises with a robust mechanism to enhance supply chain integrity and meet increasingly stringent safety standards. The company's market position is defined by its commitment to non-GMO biological solutions, which are gaining traction among sustainability-focused agricultural producers and food processors globally.
How much funding has Microgen Biotech raised?
Microgen Biotech has raised a total of $3.8M across 1 funding round:
Series A
$3.8M
Series A (2020): $3.8M with participation from SVG Ventures, Fulcrum Global Capital,, and The Yield Lab Europe
Key Investors in Microgen Biotech
SVG Ventures
A prominent venture capital firm and innovation platform specializing in the food and agriculture technology sectors.
Fulcrum Global Capital
An investment firm focused on early-to-growth stage companies that are transforming the global agricultural and food supply chains.
The Yield Lab Europe
A specialized venture capital fund dedicated to supporting sustainable agriculture technology startups that drive efficiency and environmental impact.
What's next for Microgen Biotech?
With the infusion of capital from this major strategic investment, Microgen Biotech is expected to accelerate its research and development pipeline while expanding its operational footprint. The company will likely prioritize the scaling of its manufacturing capabilities to meet the growing demand for bio-based soil amendments. Furthermore, the firm is positioned to deepen its engagement with large-scale agricultural stakeholders, focusing on long-term partnerships that integrate its microbial solutions into standard farming practices. As the company moves beyond the initial development phase, the focus will shift toward regulatory validation and the establishment of a global distribution network, ensuring that its technology can effectively address food safety challenges on a commercial scale.
See full Microgen Biotech company page
